Back
Vaxcyte Vs. Embecta Industry Stock Comparison
Buy
55
PCVX
Vaxcyte
Last Price:
115.65
Seasonality Move:
17.16%
Buy
57
EMBC
Embecta
Last Price:
13.56
Seasonality Move:
13.89%
Buy
55
Vaxcyte (PCVX)
is a Buy
Is Vaxcyte a Buy, Sell or Hold?
- The current Vaxcyte [PCVX] share price is $117.93. The Score for PCVX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PCVX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Embecta (EMBC)
is a Buy
Is Embecta a Buy, Sell or Hold?
- The current Embecta [EMBC] share price is $13.70. The Score for EMBC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- EMBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.06 | Buy |
Relative Strength Index (14 RSI): | 64.83 | Buy |
Chaikin Money Flow: | 290013 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.63 - 116.11) | Buy |
Bollinger Bands (100): | (71.16 - 106.18) | Buy |
EMBC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 46.04 | Sell |
Chaikin Money Flow: | 141397 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.21 - 15.55) | Sell |
Bollinger Bands (100): | (12.55 - 15.33) | Sell |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 113.07 | Buy |
20-day SMA: | 113.46 | Buy |
50-day SMA: | 100.77 | Buy |
200-day SMA: | 78.18 | Buy |
8-day EMA: | 114.26 | Buy |
20-day EMA: | 112.22 | Buy |
50-day EMA: | 103.58 | Buy |
200-day EMA: | 81.18 | Buy |
EMBC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.2 | Buy |
20-day SMA: | 13.97 | Sell |
50-day SMA: | 14.62 | Sell |
200-day SMA: | 14.01 | Sell |
8-day EMA: | 13.38 | Buy |
20-day EMA: | 13.85 | Sell |
50-day EMA: | 14.24 | Sell |
200-day EMA: | 14.83 | Sell |
Vaxcyte Earnings Growth & PCVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.33 per share.
Embecta Earnings Growth & EMBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.12 per share.
Vaxcyte Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Embecta Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |